Step 1: Preventing New Infections
Active Resources: 101
Reports
-
7/24/2018
-
1/1/2017
-
2/1/2016
-
9/1/2015
-
8/27/2015
-
6/25/2015
-
11/13/2014
-
9/12/2014
-
7/4/2014
-
6/11/2014
-
4/11/2014
Slide Sets
-
7/1/2018
-
4/28/2017
-
7/20/2016
-
12/15/2015
-
5/19/2015
-
5/19/2015
-
12/22/2014 (reviewed: 7/17/2015)
-
6/1/2014
-
1/15/2014
Charts, Tables & Posters
-
1/22/2018
-
7/28/2016
-
9/4/2015
-
8/1/2015
-
7/1/2015
-
2/23/2015
-
11/24/2014
-
10/24/2014
-
8/22/2014
Webinar Recordings
-
12/11/2017
-
4/13/2017
-
12/2/2016
-
6/8/2016
-
4/7/2016
-
10/26/2015
-
7/15/2015
-
7/1/2015
-
6/22/2015
-
6/4/2015 (reviewed: 10/12/2015)
-
4/30/2015 (reviewed: 10/12/2015)
-
12/10/2014
-
3/28/2014
-
1/9/2014
-
12/5/2013
-
11/21/2013
Fact Sheets
-
11/28/2017
-
12/31/2015
-
7/29/2015
-
5/5/2015
-
2/2/2015
-
2/2/2015
-
12/1/2013
Pocket Guides
-
11/15/2017
-
11/15/2016
-
10/17/2016
-
11/1/2013
Curricula
-
11/1/2017
-
12/12/2016
-
10/12/2015
-
12/17/2013
Prevention & Testing Guidelines (PEP, PrEP, PWP)
-
10/1/2017
-
6/1/2016
-
4/18/2016
-
12/11/2014
-
9/5/2014
-
5/14/2014
-
1/1/2014
Online Training
-
8/23/2017
-
9/15/2016
Toolkits
-
6/30/2017 (reviewed: 11/14/2017)
-
1/2/2017
-
5/17/2016
-
2/22/2016
-
10/30/2015
-
10/8/2015
-
8/1/2014 (reviewed: 11/30/2015)
Clinical Reference Tools
-
5/3/2017 (reviewed: 5/3/2017)
Online and Self-Paced Learning
-
11/2/2016
Videos
-
8/25/2016
-
4/1/2015
-
4/1/2015
-
1/1/2015
-
6/18/2014
-
2/4/2014
-
1/10/2014
Primary Care Guidelines
-
2/2/2016
-
11/9/2015
-
12/16/2014
-
10/29/2014
Patient Information
-
8/7/2015
Antiretroviral Guidelines
-
8/6/2015 (reviewed: 10/19/2017)
Coinfection Guidelines (Hep, TB, STIs)
-
6/5/2015
Web Links
-
3/1/2015
-
3/4/2014
-
3/4/2014
Articles & Bibliographies
-
4/21/2014
-
3/13/2014
-
3/6/2014
-
2/7/2014
-
1/30/2014
Manuals
-
11/1/2013
Archive Resources: 29
Clinical Reference Tools
-
9/10/2015
-
10/1/2012
Reports
-
7/1/2015
-
11/12/2014
-
7/15/2013
-
8/31/2011
Webinar Recordings
-
1/29/2015 (reviewed: 10/9/2015)
-
3/19/2013
-
12/12/2012
Slide Sets
-
9/5/2013
-
8/1/2013
-
9/21/2012
-
12/1/2011
-
1/1/2011
-
1/1/2010
Videos
-
9/1/2013
-
12/12/2012
Manuals
-
8/1/2013
Training Exchanges
-
6/20/2013
Fact Sheets
-
6/1/2013
Charts, Tables & Posters
-
6/1/2013 (reviewed: 1/11/2017)
Toolkits
-
3/15/2013
Curricula
-
3/8/2013
Training Program Resources
-
11/19/2012
Prevention & Testing Guidelines (PEP, PrEP, PWP)
-
8/10/2012
-
1/28/2011
-
7/18/2003
Articles: 4
-
Dolutegravir + 3TC in Initial Therapy
As we have commented in the past, initial ARV regimens consisting of 2 drugs tend to perform poorly in comparison with currently recommended 3-drug regimens. Yet, given toxicity concerns about some ARVs (particularly about tenofovir DF and abacavir) and cost concerns about 3-drug regimens, the...
-
Undetectable = Untransmittable: Effective HIV Treatment Prevents HIV Transmission
In September 2017, the U.S. Centers for Disease Control and Prevention (CDC) officially recognized that suppressing HIV through antiretroviral therapy (ART) prevents sexual transmission of HIV. In a "Dear Colleague" letter, CDC officials said, "people who take ART daily as prescribed and...
-
Addiction Recovery and HIV: Finding Synergy
When we talk about HIV and drug addiction, we most often focus on injection drug use (IDU) as a risk factor for HIV transmission. While only 2.6% of the country’s population over the age of 13 reports having injected drugs at some point during their lives1, approximately 10% of new HIV...
-
Can We Talk? Addressing Sexual Health Issues of College Students and Young Adults on HBCU Campuses
How can I learn about the sexual attitudes and practices of my students? How can I help them avoid unwanted sexual pressures? And, once they choose to be sexual, how can I help them be safely sexual?
Health care professionals who work in...
| Day | Title |
|---|---|
|
10/24 |
|
|
10/25 |
|
|
11/7 |
|
|
11/27 |
2018 Texas HIV-STD Conference
Event type: Conferences & Events
|
| Day | Title |
|---|---|
|
10/23 |